SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001493152-22-034837
Filing Date
2022-12-08
Accepted
2022-12-08 10:20:30
Documents
3
Effectiveness Date
2022-12-08

Document Format Files

Seq Description Document Type Size
1 formposex.htm POS EX 55055
2 ex4-10.htm EX-4.10 133890
3 ex4-11.htm EX-4.11 130857
  Complete submission text file 0001493152-22-034837.txt   320925
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-268038 | Film No.: 221451619
SIC: 2834 Pharmaceutical Preparations